- Home
- PHIO vs NUWE Comparison
PHIO vs NUWE Comparison
Compare PHIO & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- NUWE
- Stock Information
- Founded
- PHIO 2011
- NUWE 1999
- Country
- PHIO United States
- NUWE United States
- Employees
- PHIO N/A
- NUWE N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PHIO Health Care
- NUWE Health Care
- Exchange
- PHIO Nasdaq
- NUWE Nasdaq
- Market Cap
- PHIO 2.3M
- NUWE 2.8M
- IPO Year
- PHIO N/A
- NUWE N/A
- Fundamental
- Price
- PHIO $2.21
- NUWE $1.80
- Analyst Decision
- PHIO Strong Buy
- NUWE Buy
- Analyst Count
- PHIO 1
- NUWE 2
- Target Price
- PHIO $36.00
- NUWE $17.00
- AVG Volume (30 Days)
- PHIO 41.4K
- NUWE 7.3M
- Earning Date
- PHIO 11-14-2024
- NUWE 11-11-2024
- Dividend Yield
- PHIO N/A
- NUWE N/A
- EPS Growth
- PHIO N/A
- NUWE N/A
- EPS
- PHIO N/A
- NUWE N/A
- Revenue
- PHIO N/A
- NUWE $8,969,000.00
- Revenue This Year
- PHIO N/A
- NUWE $3.23
- Revenue Next Year
- PHIO N/A
- NUWE $17.61
- P/E Ratio
- PHIO N/A
- NUWE N/A
- Revenue Growth
- PHIO N/A
- NUWE 3.66
- 52 Week Low
- PHIO $2.17
- NUWE $1.00
- 52 Week High
- PHIO $18.81
- NUWE $31.15
- Technical
- Relative Strength Index (RSI)
- PHIO 32.01
- NUWE 50.24
- Support Level
- PHIO $2.49
- NUWE $1.55
- Resistance Level
- PHIO $3.70
- NUWE $2.57
- Average True Range (ATR)
- PHIO 0.31
- NUWE 0.51
- MACD
- PHIO -0.10
- NUWE -0.02
- Stochastic Oscillator
- PHIO 2.75
- NUWE 17.87
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.